Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash Flows From Operating Activities:
Net loss	$ (8,153,055)	$ (13,517,816)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	14,093	15,864
Amortization of patents	671,120	671,120
Issuance of stock for services	80,000
Changes in operating assets and liabilities
Settlement receivable	528,235	216,826
Prepaid expenses	30,207	(39,854)
Accounts payable - trade	41,544	1,798,759
Other accrued expenses	613,215	105,187
Accrued interest expense	969,715	401,592
Net Cash Used In Operating Activities	(5,204,926)	(10,348,322)
Cash Flows From Investing Activities:
Purchase of fixed assets		(30,400)
Net Cash Used In Investing Activities		(30,400)
Cash Flows From Financing Activities:
Proceeds from issuance of convertible notes payable	2,606,000	4,306,000
Proceeds from issuance of convertible notes payable - related parties	1,870,000	5,000,000
Proceeds from exercise of warrants	674,409	12,488
Net Cash Provided By Financing Activities	5,150,408	9,318,488
Net Decrease In Cash and Cash Equivalents	(54,518)	(1,060,234)
Cash and Cash Equivalents, Beginning of Year	105,504	1,165,738
Cash and Cash Equivalents, End of Year	50,986	105,504
Non-cash investing and financing activities:
Conversion of preferred stock into common stock		3,987
Dividend paid-in kind to preferred shareholders		1,595
Offset of related party receivable and payable	150,000	280,823
Common stock issued in satisfaction of trade debt		17,301
Notes payable issued in satisfaction of trade debt		$ 150,000